The global diabetic nephropathy market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period (2021-2027). As per CDC, diabetes is the major reason for end-stage renal disease (ESRD). Around 26 million people in the US had diabetes in 2011, and amongst them, more than 200,000 people had end-stage renal disease due to diabetes. At this stage, a kidney transplant is the only treatment that can be implemented. However, medications, kidney dialysis, and acupuncture are other possible treatments. Medication is the primary treatment given to the patients. Diuretics, angiotensin-converting enzyme inhibitors, antioxidant inflammation modulator, angiotensin receptor blockers, renin inhibitors, calcium channel blockers, monocyte chemoattractant proteins inhibitor, and G protein-coupled receptors are the prominent medications given to patients of diabetic nephropathy.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/diabetic-nephropathy-market
According to the International Journal of Advances in Medicine, around 79.4 million people will have diabetes in 2030, and by the time they get diagnosed they have been affected with some other nephropathy disease. This had given a clear vision of the growing diabetic nephropathy market in the future.
A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/diabetic-nephropathy-market
Global Diabetic Nephropathy Market Report Segment
By Indication
- Diabetes Type-1
- Diabetes Type-2
By Diagnosis
- Urine Test
- Imaging Test
- Blood Test
- Renal Function Test
- Renal Biopsy
By Treatment
- Medication
- Kidney Dialysis
- Kidney Transplant
- Acupuncture
Global Diabetic Nephropathy Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories
- Abbvie, Inc.
- Aerpio Pharmaceuticals, Inc.
- Antisense Therapeutics, Ltd.
- Astellas Pharma Europe, Ltd.
- AstraZeneca plc.
- Bayer AG
- Bristol-Myers Squibb Co.
- Cellmid, Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/diabetic-nephropathy-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
